Lido Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-100
Closed -$88.6K 1554
2024
Q3
$88.6K Hold
100
﹤0.01% 1404
2024
Q2
$90.5K Hold
100
﹤0.01% 1348
2024
Q1
$77.8K Hold
100
﹤0.01% 1331
2023
Q4
$58.3K Buy
+100
New +$58.4K ﹤0.01% 1310

Other funds holding LLY

Lido Advisors's LLY Position: Q2 2026 in Review

Lido Advisors increased its Eli Lilly (LLY) stake by 4.9% in Q2 2026, buying an estimated $5.5M and bringing the position to 114,252 shares worth $137M. The position accounts for 0.37% of the portfolio, ranked #38.

Lido Advisors first reported a position in LLY in Q1 2016 and has held it in 35 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Lido Advisors held 114,252 shares of Eli Lilly worth $137M as of Q2 2026.
  • Lido Advisors bought 5,385 Eli Lilly shares in Q2 2026, an estimated $5.5M.
  • Eli Lilly made up 0.37% of Lido Advisors's portfolio in Q2 2026, its #38 holding.
  • Lido Advisors first reported a position in Eli Lilly in Q1 2016 and has held it in 35 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Lido Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.